Abstract:The upregulation of EPH receptor B4 (EPHB4) results in a survival advantage for tumor cells via the inhibition of the casapse-8-mediated apoptotic pathway, which begins from the cell membrane. The present study investigated the expression patterns of EPHB4, ephrin B2 (EFNB2) and caspase-8 in patients with esophageal squamous cell carcinoma (ESCC). The association between the expression patterns and certain clinicopathological characteristics of the patients was also determined. mRNA levels of EPHB4, EFNB2 and caspase-8 in paired primary ESCC samples and adjacent esophageal tissues collected from 96 patients with ESCC were quantified using quantitative PCR. Upregulation of EPHB4 and EFNB2 mRNA expression, and downregulation of caspase-8 mRNA were detected in ESCC samples compared with that in the adjacent esophageal tissues. The expression levels of EPHB4 and EFNB2 were positively correlated with each other, whereas the mRNA levels of both EPHB4 and EFNB2 exhibited a negative correlation with that of caspase-8. The mRNA levels of both EPHB4 and EFNB2 demonstrated a significant positive association with certain clinicopathological features of patients with ESCC, including family history, tumor size, metastasis and stage. Conversely, a negative association was revealed between the expression level of caspase-8 and clinicopathological features of patients with ESCC. Moreover, mRNA expression levels of EPHB4 and EFNB2 were negatively associated with survival times of patients with ESCC, whereas the level of caspase-8 was positively associated with patient outcome. The results from the present study suggested that EPHB4, EFNB2 and caspase-8 may be implicated in the tumorigenesis and progression of ESCC, and that consequently, they may serve as useful prognostic markers, as well as potential therapeutic targets.

Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity

Expression of EphB4 receptor and its ligand EphrinB2 in esophageal cancer tissues and their relationship with tumor angiogenesis

Knockdown of EphB3 Inhibits Cell Proliferation Partly Through the AKT Signaling Pathway and Represses Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma

EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma

Expression Levels of EPHB4, EFNB2 and Caspase-8 Are Associated with Clinicopathological Features and Progression of Esophageal Squamous Cell Cancer

EphB4 Promotes the Proliferation, Invasion, and Angiogenesis of Human Colorectal Cancer.

EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/-catenin pathway

EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer

High Expression of EphA4 is Associated with Invasion and Lymph Node Metastasis in Colorectal Carcinomas.

Downregulation of VGLL4 in the Progression of Esophageal Squamous Cell Carcinoma

Activation of histamine H4 receptor suppresses the proliferation and invasion of esophageal squamous cell carcinoma via both metabolism and non-metabolism signaling pathways

Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway

High Expression of EphA1 in Esophageal Squamous Cell Carcinoma is Associated with Lymph Node Metastasis and Advanced Disease

Silencing EPHB2 diminished the malignant biological properties of esophagus cancer cells by blocking autophagy and Wnt/β‐catenin pathway

Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo

Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.

[Up-Regulation of ErbB3-binding Protein 1 Inhibits the Growth of Esophageal Carcinoma Cells].

KLF4 is Downregulated but Not Mutated During Human Esophageal Squamous Cell Carcinogenesis and Has Tumor Stage-Specific Functions.

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression